Received for publication June 15, 1962 FOLLOWING the researches of Jacobson and his colleagues (Jacobson et al., 1948 (Jacobson et al., , 1949a (Jacobson et al., , 1949b (Jacobson et al., , 1950 Lorenz showed that the intravenous infusion of viable isologous marrow cells prevented the death of lethally irradiated mice and guinea pigs (Lorenz et al., 1951) . Protection against lethal doses of some radiomimetic drugs has also been effected in this way (Weston et al., 1957 ; Sartorelli and LePage, 1957; Talbot and Elson, 1958; Tran Ba Loc et al., 1958; Kirschbaum, 1958; Dunjic and Maisin, 1960) . This work was extended by the Harwell Group ) when they showed that mice could be cured of leukaemia by a single large dose of radiation followed by marrow infusion. Many reports of this method of treatment, following chemotherapy as well as radiotherapy, subsequently appeared. (Trentin, 1957; Sartorelli and LePage, 1957; Barnes and Loutit, 1957; Hewitt and Wilson, 1958, 1959a; Mathe and Bernard, 1958, 1959 ; de Vries and Vos, 1958 ; Maddock and Djerassi, 1958 ; Uphoff, 1958 ; Schwartz, 1958 Schwartz, , 1959 Cole and Ellis, 1958) . This work has shown that in spite of its early promise the method does not permit the eradication of established malignant disease, but when the tumour is relatively slowly growing useful remissions may be obtained. In extending this work to man, the first essential is to decide how many marrow cells it is necessary to infuse in order to secure recovery. Because of its greater simplicity and practical importance the autologus (or isologous) situation will be considered first. Since there are good grounds for supposing that all mammalian cells have remarkably similar radiosensitivities (vide infra) the proportion of the total marrow which is effective in experimental animals should be effective in man.
The effective dose of marrow cells The various methods of assessing total marrow cellularity in animals and man are discussed in the appendix, and the value for each of the relevant species is given. In Table I the total marrow cellularity of these animals is compared with the minimum dose of marrow cells which will regularly protect all of the animals against LD100 irradiation. Such an infusion amounts to between 041 and 0 7 per cent of the total cellularity. When this is applied to man it is found that the necessary quantity of bone marrow (0.8-5*6 x 109 cells for a 70 kg. man) can be obtained and stored by techniques currently in use (Pegg and Kemp, 1960) .
Nevertheless it has been argued (Lajtha, 1959 (Lajtha, , 1960a ) that the quantity of marrow injected in human work is so small in comparison with the marrow remaining after the irradiation that the infusion would not be expected to be of benefit. This view is based on the application of radiation survival curve data to human total marrow cellularity. Although the results of such calculations can hardly affect the validity of the experimental observations referred to in the previous paragraph they have considerable theoretical interest and it will be instructive to apply this analysis to those experimental animals for which adequate radiobiological data is available.
Method of analysis
The total marrow cellularity of the relevant animals has already been referred to. A discussion of radiation survival curve data follows and an a priori examination of its applicability to the present problem is made. Following this, three sets of calculations are presented ; the first is Lajtha's comparison between the amount of marrow surviving in the lethally irradiated animal and the number of marrow cells infused in a typical experiment. In the second set of calculations the amount of marrow remaining after midlethal irradiation is compared with the sum of the surviving and injected marrow cells in lethally irradiated animals protected by bone marrow. The final calculation concerns the reduction in radiation dose which would be expected to increase the number of marrow cells surviving an LVI 100 dose by an amount equal to that contained in the marrow infusion.
Radiation survival curves
Puck and Marcus (1956) showed that when HeLa cells are irradiated in vitro, the surviving fraction is a logarithmic function of the radiation dose, survival being used in the sense of unimpaired reproductive integrity (Gray, 1959) . Radiosensitivity is best expressed as the Do value (Lea and Gray, 1956 ); this is the dose which reduces the surviving fraction to e-1 or about 37 per cent, and was found to be 140 rads in Puck's system Feldman, 1959, 1960; Hewitt and Wilson, 1960) . In a later paper (Puck et al., 1957) it was shown that a wide variety of cells derived from both normal and malignant human tissue exhibited remarkably similar survival curves. Hewitt and Wilson (1959b) described a strikingly similar curve for murine leukaemia cells irradiated and assayed in vivo (Do = 160 r 60Co) and Berry and Andrews (1961) have recently used a similar method to obtain a Do of 160 r 3 MeV X-rays for an ascitic leukaemia of DBA mice.
Thus, the radiosensitivity of many cell types of different mammalian species has been found to be almost identical. Puck (1959) made the interesting observation that the Do for yeast, avian and mammalian cells is a function of the cellular DNA content and this has also been suggested by radiosensitivity measurements in twenty-four plant species (Sparrow and Miksch, 1961) . Since the DNA content of mammalian cells is remarkably constant irrespective of species and tissue (5-0-6'0 ,au,g. per cell, Vendrely, 1955) there is now both experimental and theoretical evidence suggesting that the radiosensitivity of all cells of all mammals is very similar. There is, therefore, every justification for applying the standard survival curve to the bone marrow of all the experimental mammals and man. In doing so, the Do value of Morkovin and Feldman (140 rads) will be used since this avoids any correction for relative biological efficiency in the experiments which will be quoted; the calculations will be made on the total bone marrow numbers with the assumption that the stem cells form the same proportion of the infused marrow as they do of the bone marrow in situ. Table IV provides an even more striking illustration of the inappropriateness of this analysis. Here, the sum of the surviving and injected cells in the protected lethally irradiated animals is applied to the radiation survival curve in order to derive the radiation dose which would have been expected to result in the survival of this number of marrow cells without marrow infusion. It is found that the reduction in radiation dose equivalent to an effective marrow infusion is between 8 and 40 r; such a reduction would make veray little difference to the survival of the irradiated animals.
Results of the Analysis
From all this it is quite clear that the cells calculated to survive the radiation dose are not numerically comparable with the freshly infused cells. It seems that there are four possible reasons for this, any or all of which may operate. 1. The bone marrow cells may have a greater intrinsic radiosensitivity than all other tested cells.
2. The radiation dose absorbed by the bone marrow may be higher than that for the remaining tissues.
3. The growth rate of the cells surviving the radiation may be reduced during the crucial recovery phase.
4. A humoral factor may contribute significantly to radiation recovery after marrow injection.
These factors will now be considered in turn.
Radiosensitivity of bone marrow
It was pointed out in a previous section that there is every reason to believe that bone marrow cells have the same intrinsic radiosensitivity as other cells.
Recently, Till and McCullock (1961) have devised an ingenious technique to measure the radiosensitivity of mouse bone marrow. The method depends on the ability of marrow cells injected into irradiated recipients to form detectable splenic nodules in a fixed time; consequently it is dependent on alterations of growth rate as well as survival of reproductive capacity. The Do obtained (115 r) is slightly lower than that obtained for other cells, but this may very well be due to a temporary effect of radiation on growth rate (vide infra). In any case, the discrepancy is not great and although the possibility of increased radiosensitivity of bone marrow cannot be rejected it seems unlikely to be the principal cause of the effects noted here.
Absorbed radiation dose
It has been shown that the absorbed dose in irradiated tissues is greater when the effective atomic number is high (Spiers, 1946) and that at the boundary of a tissue such as bone, secondary electron emission delivers an increased dose to the adjacent soft tissue (Spiers, 1949 (Spiers, , 1951 Wilson, 1950; Woodard and Spiers, 1953 ). This effect is considerable up to 80 /a from a bone surface when 200 kv X-rays are used, as they were in all the experiments quoted here, and would therefore deliver a greater dose to the bone marrow than the whole-body dose. This could be highly significant if some of the effective marrow cells are intimately associated with the bone surface, where the absorbed dose may be 2-5 times as great as in distant soft tissue. The success of Lorenz and Congdon (1954) in providing radiation protection by the implantation of washed bone chips suggests that this may be so. Direct evidence favouring a high absorbed dose for bone marrow was provided by Belcher et al. (1958) when they showed that after uniform sublethal irradiation of rats splenic erythropoiesis recovered before the bone marrow. It is concluded that this phenomenon accounts at least in part for the findings presented above.
The growth rate of radiation survivors Puck and Marcus (1956) in their paper describing the radiation survival curve noted that cells surviving radiation grew more slowly than unirradiated cells. This was not due simply to a delay in the resumption of mitosis, for although the effect was certainly most striking in the period immediately following irradiation, it was still apparent as long as 10 days afterwards. The earlier work of Reid and Gifford (1952) also shows this effect; mouse fibroblasts were found to take 16 days to recover their original growth rate after 500 r. Kohn and Fogh (1959) showed that human amnion cells in tissue culture were still growing slowly 10 days after 600 r. All this does not imply that radiation survivors have a permanently depressed growth rate, but if a similar phenomenon applies to bone marrow cells it does mean that they are dividing abnormally slowly during the crucial regenerative phase following radiation.
A humoral factor
The evidence is quite overwhelming that bone marrow infusions protect by cellular repopulation (see, for example, Loutit, 1954, 1956; Ford et al., 1956; Vos et al., 1956 ), but there remains some evidence suggesting that a humoral factor may play a small part (Ellinger, 1956 Protection by homologous bone marrow infusion Quantitative data is available for four species (Table V) although the effective marrow dose given for the dog may may not be a minimum dose. It is seen that between 1P2 and 1 7 per cent of the total marrow is required for radiation protec- tioin. This would amount to between 9 and 13 X 109 cells for a 70 kg. man and proportionately less for children. The quantities required for children can easily be obtained by standard techniques, and although the amount required for adults approaches the upper limit of yields usually obtained, there is no doubt that such quantities can be obtained when the need arises. However, it is most important that the two principal hazards of this procedure should be reckoned with: the first is the mid-lethal dose effect (van Bekkum and Vos, 1957) whereby the survival rate is decreased by homologous marrow infusion at around the LD 50, and the second is the danger of producing secondary disease (Mathe et al., 1960) . Clearly, in cases of accidental radiation exposure these possibilities must be balanced against the risk to the patient of withholding the treatment, but it seems to be beyond doubt that the deliberate production of bone marrow aplasia in order to infuse homologous bone marrow is not justified at the present time. If homologous marrow infusions are to be carried out the greatest possible yield of cells should be obtained and blood contamination kept to a minimum (Goodman and Congdon, 1961 Table  VI . No clearly established example appears to have been described of successful marrow grafting following chemotherapy of an animal. It is at once obvious that the amount of isologous marrow required was greater than that used in radiation protection although the survival rate was lower. It also seems to be quite clear that better results were obtained after myeleran than after nitrogen mustard. The following explanation of these observations is offered.
Haematological recovery after radiation is much slower than it is after alkylating agents, and Elson et al. (1958) have shown that among alkylating agents nitrogen mustards permit much more rapid recovery than myeleran. It takes 1-2 weeks for bone marrow aplasia to kill, but by this time recovery is well under way in the animal treated with moderate amounts of nitrogen mustard, and even with myeleran it has started. Bone marrow infusions will therefore make relatively little difference to the outcome; consequently, it is necessary to give relatively larger doses of these drugs in order to demonstrate any benefit from the marrow infusion. However, larger doses produce toxic effects on other systems which kill the animal more rapidly than bone marrow aplasia and are not benefitted by marrow infusion.
These findings carry important implications for clinical work. In the first place, it is clearly desirable to obtain as much marrow as possible for autologous infusion. Secondly, one is not likely to obtain the best results by increasing the dose of an agent producing a transient effect on the bone marrow. Rather, one should select drugs like myeleran and mannomustine which are known to produce prolonged haemopoietic depression.
Therapeutic measures other than bone marrow infusion in lethally irradiated animals
Since the principal hazards of bone marrow hypoplasia are infection and haemorrhage, measures designed to limit these complications should promote recovery of the irradiated mammal. Also, if it were possible to stimulate the surviving bone marrow this should increase survival. These three possible therapeutic measures will now be considered.
1. Control of infection.-It has been conclusively shown that the most frequent cause of death in irradiated mice dying with the bone marrow syndrome is infection (Miller et al., 1950a (Miller et al., , 1951 . Antibiotics reduce mortality among mice receiving 450 r (Miller et al., 1950b) , but in rats irradiated to this dose (Lambert et al., 1950) and in mice receiving more than 600 r there is little or no benefit (Osborne et al., 1952) . Similar results were obtained in dogs (Allen et al., 1951) and in rabbits (Wilson et al., 1959) . Smith et al. (1955) compared marrow cell infusions with streptomycin in the treatment of irradiated hamsters and it was found that whereas the antibiotic raised the LD50 by 100 r marrow infusion raised it by 380 r. Sterile nursing is not practicable with small animals, but has been advocated in the treatment of human subjects exposed to whole body irradiation (Tubiana et al., 1961) . This measure should provide some protection against the hospital pathogens, but since the organisms which usually produce fatal septicaemia in irradiated animals are bowel commensals, barrier nursing is unlikely to improve survival. The chemotherapeutic methods available for sterilising the bowel carry a very considerable risk of producing overwhelming infection by Candida albicans and the development of antibiotic resistant bacterial strains. The systemic use of broad spectrum antibiotics is also capable of causing disseminated moniliasis, which is frequently fatal in the leukopenic patient.
2. Control of haemorrhage.-The value of fresh blood in the control of haemorrhage in irradiated dogs has been studied by Allen et al. (1951 Allen et al. ( , 1952 . It was found that even when blood was given in large amounts thrice weekly it failed to produce haemostasis or increase survival unless antibiotics were also given; then mortality fell from 100 to 80 per cent. Cronkite and Brecher (1952) were able to improve haemostasis in irradiated dogs with platelet infusions but survival did not increase: Soybean phosphatide was found to be an equally effective haemostatic (White et al., 1953) . controlled the bleeding in dogs with fresh platelets but found that lyophilised platelets were ineffective. This was confirmed in rats by Fliedner et al. (1958) . It is clear that fresh platelet infusions can arrest haemorrhage in irradiated recipients, but unless other measures are also used there is not even a modest improvement in survival.
3. Acceleration of marrow regeneration. -Lajtha (1960b) has suggested that measures to accelerate marrow regeneration may be useful in radiation protection. Unfortunately the evidence available shows only very slight benefit from such measures. Patt et al. (1955) stated in a brief communication that injection of rabbit anti-dog serum into irradiated dogs increased their survival to an unspecified degree, while Kelly and Jones (1953) reported that injections of liver or embryo homogenates increased the survival of irradiated mice from 8 to 24 per cent; an even smaller benefit was obtained by Forssburg et al. (1960) . Stohlmann's group (Stohlmann et al., 1955 (Stohlmann et al., , 1956 ) have studied the stimulation of bone marrow after 150-200 r, but this is not directly applicable to the present problem. Venesection would be expected to provide some bone marrow stimultion, but is unlikely to be acceptable in clinical work since the patients are usually already anaemic.
4. Conclulsions for human work.-None of these methods possesses the potency of autologous or isologous marrow infusion, but many of them find a place in conjunction with marrow infusion. The hospitalised patient should be sterile nursed to avoid contact with the " hospital pathogens " and, even more important, the attendants should be thoroughly screened to eliminate any carriers of dangerous pathogens. Antibiotics should be reserved for definite infections, which should be treated promptly and thoroughly. Fresh platelet transfusions should be given for thrombocytopenic haemorrhages, but if blood is required it should be irradiated to eliminate immunologically competent cells (Goodman and Congdon, 1961) .
SUMMARY AND CONCLUSIONS 1. Radiation survival curve data and total bone marrow cellularity measurements in experimental animals and man are reviewed.
2. On the basis of total bone marrow cellularity and the minimum effective marrow infusion in animal experiments it is concluded that a 70 kg. man would require 0*7-5*2 x 109 autologous marrow cells or 9-13 x 109 homologous marrow cells after lethal whole-body irradiation. Bone marrow protection is far less effective after lethal doses of radiomimetic chemotherapeutic agents. 3. When the numbers of marrow cells calculated to survive various doses of whole-body irradiation are calculated and compared with the amount of marrow infused in successful isologous marrow grafting experiments, it is found that numerical comparison gives unacceptable results ; reasons for this anomaly are suggested which avoid the proposition that marrow cells have an intrinsic radiosensitivity different from that of other somatic cells.
4. The practical care of the patient who has received large doses of wholebodv irradiation or radiomimetic chemotherapy is considered. The potency of autologous marrow infusion and the dangers of homologous marrow infusion are emphasised and the place of antibiotics, platelet and whole blood treatment is discussed.
APPENDIX Total bone marrow cellularity
It is proposed to review here the various estimates of total bone marrow cellularity which have been made in those animals for which radiobiological data are available, and in man. These include the mouse, the rat, the guinea pig, the rhesus monkey and the dog. Three techniques have been used; these may be designated the anatomical, erythrokinetic and radioiron methods. In the case of each animal the most reliable estimate will be emphasised and the estimates for the different species compared.
The anatomical method
In this technique the unit cellularity of bone marrow is multiplied by the estimated total marrow volume. Experiments have been made to estimate the total marrow cellularity of man and of the CBA mouse using this principle.
1. Man.-As much marrow as possible was collected from each of 12 human ribs excised during thoracotomies; an average of 1 2 x 109 cells was obtained SD 0-7 x 109 cells). This is taken to be the marrow content of one rib. The volume in which this marrow was contained has been estimated from Woodard and Holodny's breakdown of Mechanik's data for human total marrow volume (Woodard and Holodny, 1960; Mechanik, 1926) ; the result is 9-3 ml. which results in a rib marrow cellularity of 1-29 x 106 cells/cu. mm. Custer (1932) has showni that the rib marrow of adults is only about 30 per cent as cellular as the marrow contained in other sites. If allowance is made for this, Mechanik's estimate of total erythropoietic marrow volume (1500 ml., Mechanik, 1926) makes it possible to calculate the total marrow cellularity. The result is 8 1 x 109 cells/kg.
2. The mouse. The femora of 4 freshly killed 25 g. CBA mice were gently excised and the epiphyses removed cleanly with a new razor blade. The marrow cells were washed out of each shaft using a very fine Pasteur pipette and TC 199) with 2 5 per cent polyvinylpyrrolidone. The cell suspensions were diluted to exactly 1l0 ml. and cell counts made in a haemocytometer. Between 5 4 anld 8X4 x 106 cells were obtained from each femoral shaft.
The femoral shaft was found to be horn shaped with an eliptical cross sectioni.
Its volume was found by the following procedure: the maximum and minimum radii were measured at each end using a microscope micrometer and the length was measured with an engineer's screw micrometer; the femur was then ground down from one end using a dental carborundum wheel and radii were measured at three intermediate points; the area of each cross section was calculated from 40!9 the formula A -7 r1 r9, and the volume was measured as the area enclosed bv a graph of cross sectional area against length. From these data the unit cellularity of CBA mouse marrow was found to be 2 41 x 106 cells/cu. mm. (SD 0-20 x 106 cells/cu. mm.). The total marrow volume was assumed to be 1 65 per cent of the whole body volume and the specific gravity 1P0; the total marrow cellularity was 39-8 x 106 cells/kg. (SD 3.3 x 106 cells/kg.) .
3. Published data. The unit cellularity of rat marrow has been estimated by a histological technique (Kindred, 1942) and by the more accurate method of counting cells in suspensions made from known weights or volumes of marrow (Fruhman and Gordon, 1953; Meineke and Crafts, 1956; Awaya et al., 1960) . The two estimates for Wistar rats agree well (1.75 and 1 81 x 106/cu. mm.). Similar techniques have been used to measure the cellularity of marrow removed from the dog (Rekers and Coulter, 1948) , the guinea pig (Yoffey, 1961 ; Fand and Gordon, 1957) and the C3H mouse (Vogel, 1961 Whipple (1933) to determine the total marrow volume of adult mongrel dogs; using the additional data of Oehlbeck, Robscheit-Robbins and Whipple (1932) an erythropoietic marrow volume of 1 65 per cent of the body weight is obtained. A very painstaking study using an improved agar technique led Hudson (1958) to estimate the total haemopoietic marrow volume of the guinea pig at 1 56 per cent of the body weight. The first estimate of albino rat marrow volume was 3 0 per cent of the body weight (Fairman and Corner, 1934) , but more recent estimates have both been 1-65 per cent (Hashimoto, 1953 ; Watanabe, 1955) . It is interesting to note that the marrow volume of all these animals falls in the very narrow range of 1 56-1-7 per cent of body weight. For this reason one is confident in using the mean (1 65 per cent) in calculating mouse marrow cellularity.
V'ogel's assumption of 2 per cent is probably a little high.
The anatomical method permits the calculation of the total marrow cellularitv of mouse, rat, guiinea pig, dog and man.
The erythrokinetic method Kindred (1942) suggested that consideration of red cell production could be used to calculate total marrow cellularity, but as Patt (1957) pointed out, the data available for these calculations were not very precise. Osgood (1954) calculated the total bone marrow cellularity from an assumed red cell production rate, a normoblast maturation time, the myeloid: erythoid ratio and the ratio of proliferating to differentiating normoblasts. His result (46 x 109 cells per kg.) was an over-estimate, because the marrow reticulocyte stage was ignored; if this is allowed for on the basis that there are two marrow reticulocytes for each differentiating normoblast (Patt, 1957) for both myeloid and erythroid cells.
The erythrokinetic method has enabled the total marrow cellularity of manl, the rat and the dog to be calculated. Patt's procedure gives the total of the ervthroid and mveloid cells: in Table VlII 10 per cent has been added to allow for other cells.
The radioiron method Suit (1957) showed that the radioactive iron isotope 59Fe could be used to measure total marrow cellularity in man. He assumed that when an 59Fe salt is injected intravenously the amount of 59Fe present in the total bone marrow 24 hr. later is the same as that present in the total red cell mass on the eighth day; consequently the 59Fe taken up by the marrow can be measured. If a marrow sample is taken at 24 hr., the ratio of its cell content and 59Fe activity will be the same as the ratio of the total marrow cellularity and the total 59Fe content at 24 hr. An allowance was made for reticulocyte uptake and the total marrow cellularity calculated. Suit recognised that some of these assumptions were approximate, but it seems that the error in assessing the proportion of the 59Fe taken up by the marrow is considerable, since it has been shown that some of the iron originally cleared to the stores is utilized for haemoglobin synthesis during the eight-day period (Finch et al., 1949) . ]Donohue et al. (1958a and b) used a fixed value of 66 per cent for the proportion of the iron taken up by the bone marrow. This was derived from direct measurements in animal carcases and seems to be prepreferable to Suit's assumption.
Suit measured the total erythroid cellularity in 6 patients with malignant disease whom he thought " should not be considered normal the mean value was 16 x 1010 red cell precursors with a considerable range. Assuming a myeloid-erythroid ratio of 3: 1 and a mean bodv weight of 70 kg. this gives a total cellularity of 9-1 x 109 cells/kg. Donohue used the technique to measure the marrow cellularity of man, the rhesus monkey, the rat and the rabbit, but he made his radioactivity measurements on centrifuged marrow samples and ignored the radioactivity present in the supernatant. This activity was shown to be derived from the cytoplasm of cells which were probably included in the nucleated cell counts. Donohue's results are, therefore, probably overestimates, but since the percentages of the activity contained in the supernatants are specified it is possible to recalculate the results to allow for this. Thus, the estimate for man drops from 18 proportion to its red cell content. The inclusion of marrow reticulocytes with a higher iron uptake introduces an error here (Suit, 1957) but because of the gross dilution of marrow reticulocytes by blood reticulocytes this is less than 1 per cent. When dealing with aspirated marrow it is of course also necessary to correct the total nucleated cell count for dilution with peripheral blood leucocytes: this can be done by simple subtraction. The total marrow cellularity of eight patients with malignant disease has been measured by this method and a mean result of 11-5 x 109 cells/kg. obtained. (SD 5-3 x 109). Harrison (1962) has used the same technique to measure the cellularity of 10 haematologically normal patients and 11 cases of disseminated malignant melanoma. In the 10 normal cases marrow was removed both by excision of a rib and by needle puncture: the agreement obtained between these two methods confirms the validity of the corrections discussed above. Harrison's mean result of 10-9 x 109 cells/kg. based on 31 measurements in 21 patients is considered to be the most reliable estimate of human total marrow cellularity available at this time.
The 59Fe method has been used to calculate the total marrow cellularity of the rat, the rhesus monkey, the rabbit (not considered here) and man.
DISCUSSION
The various techniques used for the measurement of total marrow cellularity have given remarkably good agreement. The least satisfactory estimate is that for the rat, but this may be due at least in part to real variations in cellularity amongst different strains (Meinecke and Crafts, 1956 ). Nevertheless, the anatomical estimates for the Wistar rat are in good agreement: the radiation experiments quoted used Wistar rats.
It appears that marrow cellularity decreases with increasing body weight, not only of individual species (Fand and Gordon, 1957) , but also between species (Table VII) . Even so, human marrow cellularity expressed in terms of body weight is surprisingly low. This could be due to longer peripheral survival of the formed blood cells, but sufficiently reliable data to test this hypothesis are not available.
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